PriceTargets.com logo

Walgreens Boots Alliance - WBA Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $10.70
  • Forecasted Upside: -10.68%
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 5 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$11.98 As of 08/28/2025 01:00 AM ET
+0 (0.00%)
Get New Walgreens Boots Alliance Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WBA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WBA

Analyst Price Target is $10.70
▼ -10.68% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $10.70, with a high forecast of $12.00 and a low forecast of $8.50. The average price target represents a -10.68% upside from the last price of $11.98.

This chart shows the closing price for WBA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 8 polled investment analysts is to reduce stock in Walgreens Boots Alliance. This rating has held steady since February 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 10 hold ratings
  • 4 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 4 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 4 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 4 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 4 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 4 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/26/2025Morgan StanleyReiterated RatingUnderweight ➝ Underweight
6/26/2025UBS GroupReiterated RatingNeutral ➝ Neutral
2/28/2025Deutsche Bank AktiengesellschaftDowngradeHold ➝ Sell$11.00 ➝ $9.00
2/24/2025Wolfe ResearchUpgradeHold
1/31/2025Truist FinancialLower TargetHold ➝ Hold$13.00 ➝ $12.00
1/16/2025Truist FinancialBoost TargetHold ➝ Hold$10.00 ➝ $13.00
1/15/2025Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$9.00 ➝ $12.00
1/13/2025Evercore ISIBoost TargetIn-Line ➝ In-Line$9.00 ➝ $12.00
1/13/2025Bank of AmericaBoost TargetUnderperform ➝ Underperform$7.50 ➝ $8.50
12/4/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$13.00 ➝ $9.00
10/23/2024Jefferies Financial GroupLower TargetHold ➝ Hold$19.00 ➝ $9.00
10/22/2024TD CowenLower TargetBuy ➝ Buy$16.00 ➝ $14.00
10/17/2024UBS GroupBoost TargetNeutral ➝ Neutral$9.00 ➝ $10.00
10/16/2024BarclaysBoost TargetUnderweight ➝ Underweight$7.00 ➝ $8.00
10/16/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$7.50 ➝ $10.00
10/11/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$9.00 ➝ $7.00
10/7/2024Truist FinancialLower TargetHold ➝ Hold$13.00 ➝ $10.00
9/12/2024TD CowenLower TargetBuy ➝ Buy$22.00 ➝ $16.00
9/4/2024Bank of AmericaLower TargetUnderperform ➝ Underperform$11.00 ➝ $7.50
8/30/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$20.00 ➝ $15.00
7/23/2024BarclaysLower TargetUnderweight ➝ Underweight$11.00 ➝ $7.00
7/3/2024UBS GroupLower TargetNeutral ➝ Neutral$17.00 ➝ $12.00
7/2/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$22.00 ➝ $13.00
7/1/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$30.00 ➝ $20.00
7/1/2024TD CowenLower TargetBuy ➝ Buy$35.00 ➝ $22.00
6/28/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$13.00 ➝ $9.00
6/28/2024Truist FinancialLower TargetHold ➝ Hold$20.00 ➝ $13.00
6/28/2024Bank of AmericaReiterated RatingUnderperform ➝ Underperform$22.00 ➝ $11.00
6/28/2024Evercore ISILower TargetIn-Line ➝ In-Line$17.00 ➝ $10.00
6/24/2024UBS GroupLower TargetNeutral ➝ Neutral$22.00 ➝ $17.00
6/24/2024BarclaysLower TargetUnderweight ➝ Underweight$21.00 ➝ $19.00
6/3/2024Evercore ISILower TargetIn-Line ➝ In-Line$18.00 ➝ $17.00
5/31/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$16.00 ➝ $13.00
4/3/2024Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$23.00 ➝ $22.00
4/3/2024TD CowenLower TargetBuy ➝ Buy$37.00 ➝ $35.00
4/3/2024UBS GroupLower TargetNeutral ➝ Neutral$25.00 ➝ $22.00
4/1/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$21.00 ➝ $20.00
4/1/2024Truist FinancialReiterated RatingHold ➝ Hold$25.00
3/26/2024Raymond James FinancialReiterated RatingMarket Perform ➝ Market Perform
3/26/2024Bank of AmericaLower TargetUnderperform ➝ Underperform$23.00 ➝ $22.00
3/26/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$22.00 ➝ $21.00
3/18/2024Leerink PartnersLower TargetMarket Perform ➝ Market Perform$23.00 ➝ $22.00
2/26/2024Leerink PartnrsReiterated RatingMarket Perform
2/26/2024Leerink PartnersInitiated CoverageMarket Perform$23.00
2/20/2024HSBCReiterated RatingHold ➝ Reduce$27.00 ➝ $20.00
1/3/2024BarclaysInitiated CoverageUnderweight$21.00
12/22/2023HSBCInitiated CoverageHold$27.00
10/23/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$27.00 ➝ $30.00
10/13/2023Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$29.00 ➝ $26.00
10/11/2023Truist FinancialLower TargetHold ➝ Hold$30.00 ➝ $25.00
10/11/2023Evercore ISILower Target$26.00 ➝ $21.00
10/10/2023MizuhoLower TargetNeutral ➝ Neutral$31.00 ➝ $25.00
10/5/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$33.00 ➝ $27.00
9/22/2023Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$34.00 ➝ $27.00
9/5/2023Truist FinancialReiterated RatingHold ➝ Hold$30.00
8/24/2023Credit Suisse GroupLower TargetNeutral ➝ Neutral$33.00 ➝ $30.00
7/14/2023MizuhoReiterated RatingNeutral ➝ Neutral$31.00
7/3/2023Morgan StanleyLower TargetUnderweight$37.00 ➝ $27.00
6/29/2023Royal Bank Of CanadaLower Target$36.00 ➝ $29.00
6/29/2023MizuhoLower Target$35.00 ➝ $31.00
6/28/2023JPMorgan Chase & Co.Lower Target$40.00 ➝ $35.00
6/28/2023Credit Suisse GroupLower Target$41.00 ➝ $33.00
6/28/2023BarclaysLower Target$38.00 ➝ $32.00
6/28/2023Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$46.00 ➝ $34.00
6/27/2023UBS GroupLower Target$37.00 ➝ $35.00
6/13/2023MizuhoLower Target$41.00 ➝ $35.00
3/30/2023Deutsche Bank AktiengesellschaftLower TargetBuy$47.00 ➝ $46.00
3/29/2023JPMorgan Chase & Co.Boost TargetNeutral$40.00 ➝ $43.00
3/29/2023MizuhoReiterated RatingNeutral$41.00
3/29/2023UBS GroupLower TargetNeutral$39.00 ➝ $37.00
3/29/2023Truist FinancialLower TargetHold$42.00 ➝ $40.00
3/26/2023BarclaysLower Target$45.00 ➝ $43.00
3/22/2023Evercore ISILower TargetIn-Line$36.00 ➝ $35.00
2/22/2023Loop CapitalInitiated CoverageBuy$45.00
1/30/2023Morgan StanleyLower TargetUnderweight$39.00 ➝ $37.00
1/19/2023Truist FinancialLower TargetHold$44.00 ➝ $42.00
1/6/2023JPMorgan Chase & Co.Lower TargetNeutral$42.00 ➝ $40.00
1/6/2023Credit Suisse GroupLower TargetNeutral$42.00 ➝ $41.00
12/14/2022MizuhoBoost TargetNeutral$36.00 ➝ $41.00
11/28/2022UBS GroupBoost Target$40.00
11/23/2022Morgan StanleyReiterated RatingUnderweight$39.00
11/22/2022CowenUpgradeMarket Perform ➝ Outperform$43.00 ➝ $54.00
11/22/2022CowenUpgradeMarket Perform ➝ Outperform$43.00 ➝ $54.00
11/18/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$42.00
11/11/2022Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$41.00 ➝ $50.00
11/8/2022Truist FinancialBoost Target$38.00 ➝ $44.00
10/25/2022Deutsche Bank AktiengesellschaftBoost TargetHold$38.00 ➝ $41.00
10/19/2022Royal Bank Of CanadaLower TargetSector Perform$42.00 ➝ $36.00
10/14/2022Credit Suisse GroupLower TargetNeutral$43.00 ➝ $42.00
10/13/2022MizuhoLower Target$36.00
10/7/2022MizuhoLower TargetNeutral$49.00 ➝ $36.00
10/7/2022UBS GroupLower TargetNeutral$40.00 ➝ $37.00
10/3/2022Evercore ISILower TargetIn-Line$41.00 ➝ $32.00
9/22/2022Deutsche Bank AktiengesellschaftLower TargetHold$44.00 ➝ $38.00
7/8/2022JPMorgan Chase & Co.Lower TargetNeutral$52.00 ➝ $45.00
7/6/2022Morgan StanleyLower TargetUnderweight$43.00 ➝ $39.00
7/5/2022Royal Bank Of CanadaLower TargetSector Perform$46.00 ➝ $42.00
7/1/2022Deutsche Bank AktiengesellschaftLower TargetHold$46.00 ➝ $44.00
7/1/2022Truist FinancialLower TargetHold$50.00 ➝ $42.00
7/1/2022Credit Suisse GroupLower TargetNeutral$52.00 ➝ $43.00
6/24/2022BarclaysLower TargetEqual Weight$50.00 ➝ $45.00
6/9/2022CowenLower Target$49.00
6/2/2022Morgan StanleyLower TargetUnderweight$50.00 ➝ $43.00
4/12/2022CowenLower Target$55.00 ➝ $50.00
4/12/2022CowenLower Target$55.00 ➝ $50.00
4/5/2022Deutsche Bank AktiengesellschaftLower TargetHold$52.00 ➝ $46.00
4/5/2022UBS GroupLower TargetNeutral$52.00 ➝ $49.00
4/1/2022BarclaysLower TargetEqual Weight$54.00 ➝ $50.00
4/1/2022Truist FinancialLower TargetHold$58.00 ➝ $50.00
4/1/2022Royal Bank Of CanadaLower TargetSector Perform$52.00 ➝ $46.00
4/1/2022Robert W. BairdDowngradeOutperform ➝ Neutral$70.00 ➝ $51.00
1/10/2022MizuhoBoost Target$51.00 ➝ $56.00
12/22/2021UBS GroupBoost TargetNeutral$50.00 ➝ $52.00
12/16/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight$56.00 ➝ $49.00
10/15/2021Truist FinancialBoost TargetHold$52.00 ➝ $56.00
9/24/2021Credit Suisse GroupReiterated RatingHold$48.00
9/3/2021Robert W. BairdReiterated RatingBuy$68.00
7/6/2021BarclaysLower TargetEqual Weight$55.00 ➝ $53.00
7/2/2021Evercore ISIReiterated RatingHold$52.00
7/2/2021Wolfe ResearchReiterated RatingHold$57.00
7/2/2021Truist FinancialLower TargetHold ➝ Hold$58.00 ➝ $52.00
7/2/2021Deutsche Bank AktiengesellschaftLower TargetHold$55.00 ➝ $52.00
7/2/2021Credit Suisse GroupLower TargetNeutral$50.00 ➝ $48.00
7/2/2021Robert W. BairdLower TargetPositive ➝ Outperform$72.00 ➝ $68.00
6/29/2021Credit Suisse GroupReiterated RatingHold$50.00
6/14/2021Robert W. BairdReiterated RatingBuy
6/9/2021Deutsche Bank AktiengesellschaftReiterated RatingHold
5/19/2021Robert W. BairdReiterated RatingBuy
5/12/2021MizuhoBoost TargetPositive ➝ Neutral$47.00 ➝ $55.00
4/14/2021Morgan StanleyBoost TargetEqual Weight$52.00 ➝ $60.00
4/5/2021BarclaysBoost TargetEqual Weight$47.00 ➝ $55.00
4/1/2021Royal Bank Of CanadaBoost Target$44.00 ➝ $52.00
4/1/2021Truist FinancialBoost Target$50.00 ➝ $58.00
4/1/2021Credit Suisse GroupBoost TargetNeutral$46.00 ➝ $50.00
3/30/2021Morgan StanleyBoost TargetEqual Weight$40.00 ➝ $52.00
3/29/2021CowenBoost TargetMarket Perform$41.00 ➝ $53.00
3/25/2021Deutsche Bank AktiengesellschaftBoost TargetHold$49.00 ➝ $55.00
1/27/2021Deutsche Bank AktiengesellschaftBoost TargetHold$44.00 ➝ $49.00
1/11/2021GuggenheimUpgradeNeutral ➝ Buy$55.00
1/11/2021MizuhoBoost TargetPositive ➝ Neutral$37.00 ➝ $47.00
1/11/2021Robert W. BairdUpgradeNeutral ➝ Outperform$41.00 ➝ $55.00
1/8/2021Truist FinancialBoost Target$44.00 ➝ $48.00
1/8/2021BarclaysBoost TargetEqual Weight$40.00 ➝ $47.00
1/8/2021Deutsche Bank AktiengesellschaftBoost TargetHold$41.00 ➝ $44.00
1/7/2021Credit Suisse GroupInitiated CoverageNeutral$42.00
1/5/2021Truist FinancialBoost Target$40.00 ➝ $44.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.82 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 62 very positive mentions
  • 31 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 52 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 47 very positive mentions
  • 35 positive mentions
  • 3 negative mentions
  • 4 very negative mentions
Mentions as of
7/8/2025
  • 35 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 56 very positive mentions
  • 25 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/6/2025
  • 2 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Walgreens Boots Alliance logo
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Read More

Today's Range

Now: $11.98
Low: $11.98
High: $11.98

50 Day Range

MA: $11.89
Low: $11.52
High: $12.20

52 Week Range

Now: $11.98
Low: $8.08
High: $13.25

Volume

N/A

Average Volume

35,941,780 shs

Market Capitalization

$10.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Walgreens Boots Alliance?

The following equities research analysts have issued research reports on Walgreens Boots Alliance in the last year: Bank of America Corporation, Deutsche Bank Aktiengesellschaft, Evercore ISI, Morgan Stanley, Royal Bank Of Canada, Truist Financial Corporation, UBS Group AG, Wall Street Zen, and Wolfe Research.
View the latest analyst ratings for WBA.

What is the current price target for Walgreens Boots Alliance?

0 Wall Street analysts have set twelve-month price targets for Walgreens Boots Alliance in the last year. Their average twelve-month price target is $10.70, suggesting a possible downside of 10.7%. Truist Financial Corporation has the highest price target set, predicting WBA will reach $12.00 in the next twelve months. Bank of America Corporation has the lowest price target set, forecasting a price of $8.50 for Walgreens Boots Alliance in the next year.
View the latest price targets for WBA.

What is the current consensus analyst rating for Walgreens Boots Alliance?

Walgreens Boots Alliance currently has 3 sell ratings and 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for WBA.

What other companies compete with Walgreens Boots Alliance?

Other companies that are similar to Walgreens Boots Alliance include CVS Health, Herbalife, Target, eBay and Expedia Group. Learn More about companies similar to Walgreens Boots Alliance.

How do I contact Walgreens Boots Alliance's investor relations team?

Walgreens Boots Alliance's physical mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator's listed phone number is (847) 315-3700 and its investor relations email address is [email protected]. The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com. Learn More about contacing Walgreens Boots Alliance investor relations.